Compounds > bromopyruvate
Page last updated: 2024-08-25

bromopyruvate and Carcinoma

bromopyruvate has been researched along with Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Can, Z; Chenchen, J; Lele, S; Lingling, L; Liu, H; Pei, Z; Qiong, P; Surong, Z; Yiming, S; Yuzhong, C; Zhirui, Z1
Jiang, C; Liu, H; Sun, Y; Wei, Y; Zhang, M; Zhang, X; Zhao, S; Zou, X1

Other Studies

2 other study(ies) available for bromopyruvate and Carcinoma

ArticleYear
3-Bromopyruvate enhances TRAIL-induced apoptosis in human nasopharyngeal carcinoma cells through CHOP-dependent upregulation of TRAIL-R2.
    Anti-cancer drugs, 2017, Volume: 28, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma; Cell Line, Tumor; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pyruvates; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP; Transfection; Up-Regulation

2017
Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells.
    Oncology reports, 2015, Volume: 34, Issue:4

    Topics: Animals; Apoptosis; Carcinoma; Cell Line, Tumor; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pyruvates; Reactive Oxygen Species; Xenograft Model Antitumor Assays

2015